Management of Diffuse Low-Grade Glioma: The Renaissance of Robust Evidence
Karanbir Brar, Laureen D. Hachem, Jetan H. Badhiwala et al. · Frontiers in Oncology · 2020
Abstract onlyNot checked
Medicine: papers
Filters1 filter applied
Status
- Corrected
- No notice
- Not checked
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
646 Evaluating a preclinical model of contact hypersensitivity for skin immune checkpoint toxicity
Yong Liu, Niroshana Anandasabapathy, Barbara Ma et al. · Journal for ImmunoTherapy of Cancer · 2020
Abstract onlyNot checked
Resistance to Arsenic- and Antimony-Based Drugs
Milena Salerno, Arlette Garnier-Suillerot · Bioinorganic Chemistry and Applications · 2003
Abstract onlyNot checked
458 Antitumor mechanisms of local radiation and combination immunotherapy in an immunologically cold model of neuroblastoma
Paul Sondel, Alexander Rakhmilevich, Taylor Aiken et al. · Journal for ImmunoTherapy of Cancer · 2020
Abstract onlyNot checked
Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells.
Nupur Nigam, Abhinav Grover, Sukriti Goyal et al. · PLoS ONE · 2015
Abstract onlyNot checked
Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance
Fanming Kong, Fanming Kong, Ziwei Wang et al. · Frontiers in Oncology · 2021
Abstract onlyNot checked
A Prospective and Retrospective Clinical Controlled Observation of Chinese Herbal Decoction (SMLJ01) for Type 1 Gastric Neuroendocrine Tumors
Yingying Chen MD, Deng Han MD, Jiqing Zhu MD et al. · Integrative Cancer Therapies · 2020
Abstract onlyNot checked
Validation of serrated polyps (SPs) in Swedish pathology registers
Soran R. Bozorg, Mingyang Song, Louise Emilsson et al. · BMC Gastroenterology · 2019
Abstract onlyNot checked
Comparison of the Efficacy of D2 Gastrectomy Plus Liver Radiofrequency Combined With Chemotherapy Versus Chemotherapy Alone in the Treatment of Advanced Gastric Cancer With Unresectable Synchronous Liver Metastases: A Multicenter Randomized Controlled Trial Protocol
Weidong Wang, Ruiqi Gao, Pengfei Yu et al. · Frontiers in Oncology · 2022
Abstract onlyNot checked
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
Enrica Vescarelli, Giulia Gerini, Francesca Megiorni et al. · Journal of Experimental & Clinical Cancer Research · 2020
Abstract onlyNot checked
ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women With HER2-Positive Breast Cancer: A Study Protocol
Atara I. Ntekim, Abiola Ibraheem, Adenike A. Sofoluwe et al. · JCO Global Oncology · 2020
Abstract onlyNot checked
Turning tolerogenic into immunogenic ileal cell death through ileal microbiota: the key to unlock the mystery of colon cancer immunoscore?
Maria Paula Roberti, Marion Picard, Satoru Yonekura et al. · OncoImmunology · 2020
Abstract onlyNot checked
Clinical development of targeted and immune based anti-cancer therapies
N. A. Seebacher, A. E. Stacy, G. M. Porter et al. · Journal of Experimental & Clinical Cancer Research · 2019 · Review
Full textCC BY
Metal Complexes, an Untapped Source of Antibiotic Potential?
Angelo Frei · Antibiotics · 2020
Abstract onlyNot checked
Behavioral factors to modulate immunotherapy efficacy in cancer
C. Jongerius, C. Jongerius, C. Jongerius et al. · Frontiers in Immunology · 2022
Abstract onlyNot checked
Managing Resident Workforce and Education During the COVID-19 Pandemic
Andrew M. Schwartz, MD, Jacob M. Wilson, MD, Scott D. Boden, MD, FAOA et al. · JBJS Open Access · 2020
Abstract onlyNot checked
Platinum and ruthenium complexes as promising molecules in cancer therapy
Avramović Nataša, Ignjatović Nikola, Savić Aleksandar · Srpski Arhiv za Celokupno Lekarstvo · 2019
Abstract onlyNot checked
Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin
Lauren MacDonagh, Rhyla Mae Santiago, Steven G. Gray et al. · Translational Oncology · 2021
Abstract onlyNot checked
Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling
Heike Reeh, Nadine Rudolph, Ulrike Billing et al. · Cell Communication and Signaling · 2019
Full textCC BY
Mechanisms of resistance to immune checkpoint inhibitors and strategies to reverse drug resistance in lung cancer
Fang-Fei Qian, Bao-Hui Han, Pei-Fang Wei · Chinese Medical Journal · 2020
Abstract onlyNot checked